KR20150025861A - Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof - Google Patents
Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof Download PDFInfo
- Publication number
- KR20150025861A KR20150025861A KR20130103969A KR20130103969A KR20150025861A KR 20150025861 A KR20150025861 A KR 20150025861A KR 20130103969 A KR20130103969 A KR 20130103969A KR 20130103969 A KR20130103969 A KR 20130103969A KR 20150025861 A KR20150025861 A KR 20150025861A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- weight
- parts
- mulberry
- lotus
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 62
- 240000000249 Morus alba Species 0.000 title claims abstract description 14
- 235000008708 Morus alba Nutrition 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 title abstract description 4
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 235000017926 Celtis australis Nutrition 0.000 title abstract 2
- 244000256534 Celtis australis Species 0.000 title abstract 2
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 14
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 9
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 6
- 230000032683 aging Effects 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 9
- 240000000599 Lentinula edodes Species 0.000 claims description 8
- 241001474374 Blennius Species 0.000 claims description 6
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 6
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 238000006748 scratching Methods 0.000 claims description 2
- 230000002393 scratching effect Effects 0.000 claims description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 208000007502 anemia Diseases 0.000 abstract description 2
- 230000003078 antioxidant effect Effects 0.000 abstract description 2
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000005070 ripening Effects 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 10
- 239000012535 impurity Substances 0.000 description 10
- 239000011734 sodium Substances 0.000 description 10
- 229910052708 sodium Inorganic materials 0.000 description 10
- 239000000463 material Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 244000303040 Glycyrrhiza glabra Species 0.000 description 5
- 238000005202 decontamination Methods 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 235000019643 salty taste Nutrition 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000036506 anxiety Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 230000000324 neuroprotective effect Effects 0.000 description 2
- 235000021023 sodium intake Nutrition 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 241000510678 Falcaria vulgaris Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000012928 buffer substance Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 230000014508 negative regulation of coagulation Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 238000009938 salting Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 연과 뽕나무 추출물을 포함한 소금 및 그 제조방법에 관한 것으로, 더욱 상세하게는 연잎, 뽕나무 등의 재료를 열수추출한 추출물을 천일염과 함께 가열하는 전통적인 방법으로 제조한 소금 및 그 제조방법에 관한 것이다.More particularly, the present invention relates to a salt prepared by a conventional method of heating an extract obtained by hot-water extraction of a material such as a lotus leaf and a mulberry, together with a salt of a salt, and a method for producing the salt will be.
소금의 나트륨은 체내에서 혈액이나 그 밖의 체액의 알칼리성을 유지하고, 쓸개즙·이자액 등 알칼리성 소화액의 성분 등 중요한 구실을 하고 있기 때문에 동물에게 생리적으로 필수적인 것이다. 소금의 나트륨은 체내에서 탄산과 결합하여 중탄산염이 되고, 혈액이나 그밖의 체액의 알칼리성을 유지하는 구실을 한다. 또 인산과 결합한 것은 완충물질로서 체액의 산, 알칼리의 평형을 유지시키는 구실을 한다.Sodium salt is physiologically necessary for animals because it maintains the alkalinity of blood or other body fluids in the body and plays an important role in the alkaline digestive juices such as bile and interest. Salt of sodium is combined with carbonic acid in the body to become bicarbonate, and serves to maintain the alkalinity of blood or other body fluids. In addition, it binds with phosphoric acid as a buffer substance and serves to maintain equilibrium of acid and alkali of body fluids.
인간의 혈액 속에는 0.9%의 염분이 함유되어 있으며, 나트륨은 쓸개즙·이자액·장액 등 알칼리성의 소화액 성분이 된다. 만일 나트륨 섭취량이 부족하면 이들의 소화액 분비가 감소하여 식욕이 떨어진다. 또한 나트륨은 식물성 식품 속에 많은 칼륨과 항상 체내에서 균형을 유지하고 있다. 칼륨이 많고 나트륨이 적으면 생명이 위태롭게 되는 경우도 생긴다.0.9% of saline is contained in human blood, and sodium is alkaline digestive fluid component such as bile, interest, and intestinal fluid. If sodium intake is low, their digestive juices are reduced and their appetite declines. In addition, sodium is always balanced in the body with many potassium in the vegetable food. When potassium is high and sodium is low, life may be endangered.
이상과 같이 체내에서 나트륨이 결핍되면 단기적인 경우에는 소화액의 분비가 부족하게 되어 식욕감퇴가 일어나고, 장기적인 경우에는 전신무력·권태·피로나 정신불안 등이 일어난다. 또 땀을 다량으로 흘려 급격히 소금을 상실하면 현기증·무욕·의식혼탁·탈력 등 육체적으로나 정신적으로도 뚜렷한 기능상실이 일어난다.As described above, when sodium is deficient in the body, in the short term, the secretion of digestive juice becomes insufficient and an appetite decline occurs, and in the long term, general anxiety, boredom, fatigue and mental anxiety occur. In addition, if sweat is poured in a large amount and the salt is suddenly lost, a significant loss of function both physically and mentally occurs such as dizziness, insomnia, unconsciousness turbidity, and depression.
하지만, 나트륨이 결핍되는 경우는 드물며, 오히려 과잉 섭취로 인하여 발생하는 문제가 더 심각하다. 세계보건기구(WHO)에서 정한 나트륨 하루 섭취 권장량은 성인 기준 2,000mg 미만이지만, 김치·장류 등 소금이 많이 들어간 음식을 매일 먹는 한국인의 식단으로 인해 2010년 한국인 하루 평균 나트륨 섭취량은 4,878mg으로 세계보건기구(WHO) 권고량 2,000mg의 2.4배에 달하는 것으로 나타났으며, 특히 30~40대 남자 나트륨 섭취량은 6,808mg으로 WHO 권고량의 3.4배에 달하는 세계 최고수준으로 조사되었다.However, deficiency of sodium is rare, and problems caused by overdose are more serious. Although the World Health Organization (WHO) recommended daily intake of sodium is less than 2,000 mg per adult, due to the diet of Koreans who eat daily high-salt foods such as kimchi and soups, the average daily sodium intake for Koreans in 2010 was 4,878 mg, It was 2.4 times higher than the recommended amount of 2,000 mg of WHO. In particular, the intake of sodium in males in their 30s and 40s was 6,808 mg, which is 3.4 times higher than the WHO recommended amount.
나트륨은 과다 섭취 시 혈액의 양을 증가시켜 고혈압을 유발하며, 배출 시 칼슘과 함께 배출되어 골다공증을 일으킬 수 있다. Sodium can cause hypertension by increasing the amount of blood at the time of overdose, and it can be released together with calcium at the time of discharge to cause osteoporosis.
이처럼, 나트륨이 하루 권장량의 2~3배 이상이 되면 위축성 위염 및 위암, 뇌경색, 뇌동피부노화, 혈액순환 장애, 고혈압, 골다공증, 신장·심장질환 등의 신체에 직접 영향을 미치는 질병 등이 유발되기 쉽다.Thus, when sodium is more than 2 times three times the recommended daily dose, it causes diseases that directly affect the body such as atrophic gastritis and gastric cancer, cerebral infarction, cerebral aging, blood circulation disorder, hypertension, osteoporosis, kidney and heart disease easy.
한국공개특허 제 2005-80502 호는 녹차, 다시마, 대잎, 연잎, 뽕잎, 감잎, 솔잎의 분말을 소금과 혼합한 기술을 개시하여 상기 제 잎들의 유효성분을 소금과 함께 제공함을 목적으로 하고 있으나, 상기 제 잎들의 유효성분이 소금과 유기적으로 결합되지 않아 섭취하는 대상으로의 전달효율이 의문시된다.Korean Patent Laid-Open Publication No. 2005-80502 discloses a technique of mixing powder of green tea, kelp, tea leaf, long leaf, mulberry leaf, persimmon leaf and pine leaf with salt to provide an effective ingredient of the leaves together with salt. However, Since the effective components of the leaves are not organically bound to the salt, the delivery efficiency to the ingested subject is questionable.
따라서, 소금의 짠맛을 감소시키면서도 동시에 각종 영양소를 효과적으로 섭취할 수 있는 저염식 기능성 소금에 대한 요구가 증가하고 있는 실정이다.Accordingly, there is a growing demand for low-salt functional salts which can effectively absorb various nutrients while reducing the salty taste of salt.
본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로서, 연잎 및 뽕나무 성분을 천일염에 포함시킴으로써 짠맛을 제공하는 소금의 기능 이외에 항산화활성 및 빈혈 예방 등에 효과가 있는 각종 영양소를 효과적으로 섭취할 수 있는 소금의 제조방법을 제공하는 것을 그 목적으로 한다.The present invention has been conceived to solve the above-mentioned problems. It is an object of the present invention to provide a method for producing salted and mulberry products, which comprises salting and mulberry ingredients, And a method for producing the same.
또한, 본 발명은 상기 제조방법으로 제조된 소금을 제공하는 것을 또 다른 목적으로 한다.It is another object of the present invention to provide a salt prepared by the above-described method.
본 발명의 소금 제조방법은 상술한 바와 같은 목적을 달성하기 위하여,In order to achieve the above-mentioned object,
(A) 물 100 중량부 당,(A) 100 parts by weight of water,
연잎 및 연대 4 내지 8 중량부, 4 to 8 parts by weight of lotus leaf and date,
뽕나무 가지 및 뿌리 11 내지 25 중량부, 11 to 25 parts by weight of mulberry branches and roots,
다시마 3 내지 8 중량부, 3 to 8 parts by weight of kelp,
표고버섯 3 내지 8 중량부, 및 3 to 8 parts by weight of shiitake mushroom, and
감초 0.5 내지 2 중량부를 포함하는 재료를 첨가하고 12 내지 20시간 동안 가열하여 진액을 제조하는 단계; 0.5 to 2 parts by weight of licorice is added and heated for 12 to 20 hours to prepare a seaweed;
(B) 천일염을 용기에 넣고 270 내지 350℃의 온도에서 4 내지 7시간 동안 상기 용기의 바닥을 긁으며 가열하고, 5 내지 10회에 걸쳐 상기 진액을 상기 천일염에 첨가하여 제염하는 단계; 및(B) placing the salt in a container, scratching and heating the bottom of the container for 4 to 7 hours at a temperature of 270 to 350 DEG C, and adding the salt to the salt for 5 to 10 times to decontaminate; And
(C) 상기 단계 (B)에서 제염한 소금을 42 내지 50℃에서 20 내지 60일 동안 숙성시키는 단계를 포함하는 것을 특징으로 한다.(C) aging the salt decontaminated in step (B) at 42 to 50 DEG C for 20 to 60 days.
또한, 상기 단계 (B)의 용기는 가마솥일 수 있다.The container of step (B) may be a cauldron.
또한, 상기 단계 (C)의 숙성은 황토로 된 숙성실에서 이루어질 수 있다.Further, the aging of the step (C) may be carried out in the aging room made of loess.
또한, 본 발명의 소금 제조방법은 상기 단계 (C) 이후에, 상기 숙성된 소금 100 중량부 당 연근분말 7 내지 15 중량부를 혼합하는 단계를 더 포함할 수 있다.In addition, the salt production method of the present invention may further comprise, after the step (C), mixing 7 to 15 parts by weight of a lotus root powder per 100 parts by weight of the aged salt.
또한, 상기 단계 (C)는 소금을 옹기에 넣어 숙성시킬 수 있다.In addition, the step (C) may be carried out by adding salt to the pot.
한편, 본 발명의 소금은 상기 제조방법으로 제조된 것을 특징으로 한다.On the other hand, the salt of the present invention is characterized by being produced by the above-mentioned production method.
본 발명의 소금은 뽕나무, 다시마, 표고버섯, 감초, 연잎 등의 재료들로 만든 진액을 이용하여 소금을 제조함으로써, 소금 본연의 기능뿐만 아니라 각종 재료들이 지니고 있는 항암효과, 신경보호 효과, 고혈압 예방효과, 중금속 배출 및 이뇨작용 등의 효과를 제공할 수 있다. The salt of the present invention can be prepared by using salt of mine, kelp, shiitake mushroom, liquorice, lotus leaf, and so on to produce salt, so that it can be used not only as a salt but also as an anticancer effect, neuroprotective effect, Effects, heavy metal emissions, and diuretic effects.
또한, 재료를 장작불을 이용하여 가마솥으로 가열하는 제염과정에서 원적외선이 방출되는데 이는 각 재료들의 천연 생리활성물질을 효율적으로 활성화시키는 효과가 있다.In addition, far-infrared rays are emitted during the decontamination process in which the material is heated by a cauldron using wood fires, which effectively activates natural physiologically active substances of the respective materials.
또한, 숙성 단계에서 옹기를 사용하여 소금을 숙성시킴으로써 부패 및 불순물로부터의 오염 걱정 없이 장기간 저장할 수 있는 장점이 있으며, 황토로 된 숙성실을 사용하여 황토로부터 발생된 원적외선이 유해물질을 제거하면서 소금의 쓴맛과 짠맛은 순화시키고 불순물은 제거된 소금을 얻을 수 있다.In addition, by aging the salt using the pottery in the aging stage, the salt can be stored for a long period of time without worrying about corruption and contamination from the impurities. The far infrared ray generated from the loess is removed from harmful substances by using a yellow- And salt can be obtained by purifying the salty taste and removing the impurities.
그리고, 소금을 가열하여 제염하는 과정에서 소금에 함유된 독성 및 불순물이 수분과 함께 증발되어 짠맛을 감소시킴으로써 인체에 유익한 저염 소금을 만들 수 있는 것이 또 하나의 특징이다.In addition, it is another feature that the salt and the toxic and impurities contained in the salt are evaporated together with the water to reduce the salty taste in the process of heating and decontaminating the salt, thereby making the salty salt beneficial to the human body.
이하, 본 발명의 바람직한 실시예에 대하여 상세히 설명한다. 또한, 하기의 설명에서는 구체적인 구성요소 등과 같은 많은 특정사항들이 설명되어 있는데, 이는 본 발명의 보다 전반적인 이해를 돕기 위해서 제공된 것일 뿐 이러한 특정 사항들 없이도 본 발명이 실시될 수 있음은 이 기술분야에서 통상의 지식을 가진 자에게는 자명하다 할 것이다. 그리고, 본 발명을 설명함에 있어서, 관련된 공지 기능 혹은 구성에 대한 구체적인 설명이 본 발명의 요지를 불필요하게 흐릴 수 있다고 판단되는 경우 그 상세한 설명을 생략한다.Hereinafter, preferred embodiments of the present invention will be described in detail. In the following description, numerous specific details, such as specific elements, are set forth in order to provide a thorough understanding of the present invention, and it is to be understood that the present invention may be practiced without these specific details, It will be obvious to those who have knowledge of. In the following description of the present invention, a detailed description of known functions and configurations incorporated herein will be omitted when it may make the subject matter of the present invention rather unclear.
본 발명의 소금 제조방법은 연잎 및 연대, 뽕나무 가지 및 뿌리, 다시마, 표고버섯, 감초를 세척하고 불순물을 제거하는 단계로부터 시작한다. 재료의 세척은 일반적으로 깨끗한 물로 수회 반복하여 실시하게 되며 세척과 동시에 불순물이 제거된다.The salt production method of the present invention starts with washing the leaves of kelp and algae, mulberry branches and roots, kelp, shiitake, licorice and removing impurities. Washing of the material is generally carried out repeatedly several times with clean water, and impurities are removed at the same time as washing.
연잎 및 연대는 혈압, 당뇨, 다이어트에 효과적이며 빈혈 예방에 좋고, 이뇨작용이 탁월하여 혈관 내 어혈을 푸는데 효과가 있으며 또한 오래 복용하면 미용과 정력에 좋은 작용을 한다. Yeonpyeong and Yantai are effective for blood pressure, diabetes, diet, good anemia prevention, excellent diuretic effect and effective for relieving intravascular haemorrhage.
뽕나무의 껍질은 예로부터 상백피라는 약재로 당뇨병 및 고혈압 치료에 이용되어 왔으며, 뽕나무 줄기와 뿌리에는 뛰어난 항암활성, 항산화활성, 신경보호 효과를 가진 resveratrol이 존재하고 있다.The bark of mulberry has been used for the treatment of diabetes and hypertension since ancient times, and the resveratrol has excellent anticancer activity, antioxidant activity and neuroprotective effect in the stem and root of mulberry.
다시마에는 식이섬유가 35~75% 함유되어 있으며 그중 수용성 식이섬유가 51~85%인 건강 식품 소재이다. 다시마의 다당류인 알긴산은 중금속을 체외로 배출하며, 혈압상승을 억제하고 콜레스테롤과 혈당을 강화시키는 작용이 각종 논문을 통해 보고되고 있다. 또한, 근래에는 다시마의 fucoidan이란 다당류가 항혈액응고 및 혈액정화 활성이 높은 것으로 알려져 있다.Kelp contains 35-75% of dietary fiber, among which health food is 51 ~ 85% soluble fiber. Alginate, a polysaccharide of sea tangle, is known to excrete heavy metals to the outside of the body, to suppress the rise of blood pressure, and to strengthen cholesterol and blood sugar. Recently, polysaccharides such as fucoidan of sea tangle have been known to have high anticoagulant activity and blood purification activity.
표고버섯은 혈장 콜레스테롤 저하, 동맥경화 및 고혈압 예방 치료 효과가 있으며, 다당류에 의한 강한 항암효과와 B형 간염 치료 효과가 있다. 또한, 표고버섯에는 칼슘의 흡수를 도와주는 비타민D가 풍부하며, 인체의 면역력을 향상시키는 B-glucan이라는 다당류가 많이 함유되어 있다.Shiitake mushrooms have the effect of reducing plasma cholesterol, atherosclerosis and hypertension, and have strong anticancer effect by polysaccharide and hepatitis B treatment effect. In addition, shiitake mushrooms are rich in vitamin D to help absorption of calcium, B-glucan to improve the body's immune system contains a lot of polysaccharides.
감초는 특이한 냄새가 나며 맛은 달고, 모든 약의 독성을 조화시켜서 약효가 잘 나타나게 하며 장부의 한열과 사기를 다스리고 모든 혈맥을 잘 소통시키며 근육과 뼈를 튼튼히 한다. 해독작용, 간염, 두드러기, 피부염, 습진, 근육이완, 이뇨작용, 항염작용 등의 효과가 있으며 소화성궤양을 억제하는 효과가 있다.Licorice has a characteristic odor, flavor, harmonizes the toxicity of all medicines, makes it appear better, regulates the fever and morale of books, communicates all blood vessels, and strengthens muscles and bones. It has the effect of detoxification, hepatitis, urticaria, dermatitis, eczema, muscle relaxation, diuretic action, anti-inflammatory action and has the effect of suppressing peptic ulcer.
상기 세척과정을 거친 후, 물 100 중량부 당 연잎 및 연대 4 내지 8 중량부, 뽕나무 가지 및 뿌리 11 내지 25 중량부, 다시마 3 내지 8 중량부, 표고버섯 3 내지 8 중량부, 및 감초 0.5 내지 2 중량부를 첨가하고 12 내지 20시간 동안 가열하여 진액을 제조한다.After the above washing process, 4 to 8 parts by weight of leaves and ages, 11 to 25 parts by weight of mulberry leaves and roots, 3 to 8 parts by weight of kelp, 3 to 8 parts by weight of shiitake mushrooms, 2 parts by weight is added and heated for 12 to 20 hours to prepare a seaweed.
상기 단계에 의해 진액이 제조되면 별도의 천일염을 용기에 넣고 270 내지 350℃의 온도에서 4 내지 7시간 동안 상기 용기의 바닥을 긁으며 가열하면서, 5 내지 10회에 걸쳐 상기 진액을 상기 천일염에 첨가하여 제염한다. 본 과정에서 각 재료의 불순물 및 천일염에 함유된 독성이 수분과 함께 증발되며, 짠맛이 감소하게 된다. 가열 과정의 온도가 상기 범위보다 낮거나, 가열시간이 상기 범위 미만이면 수분 증발과정이 충분히 이루어지지 않거나 제염 시간이 지나치게 길어질 수 있다. 가열 과정의 온도가 상기 범위보다 높거나, 가열시간이 상기 범위를 초과하여 필요 이상으로 제염되는 경우 고온에 재료가 변질되고, 소금의 색이 변하는 문제가 발생할 수 있다.When the seaweed is prepared by the above step, a separate salt of the sun salt is put into the vessel, and the bottom of the vessel is scratched and heated at a temperature of 270 to 350 ° C for 4 to 7 hours, and the seaweed is added to the sun salt for 5 to 10 times And decontamination. In this process, the toxicities of impurities and sun salt of each material are evaporated together with moisture and the salty taste is decreased. If the temperature of the heating process is lower than the above range or the heating time is lower than the above range, the process of evaporating water may not be sufficiently performed or the decontamination time may become excessively long. If the temperature of the heating process is higher than the above range or the heating time exceeds the above range, the material may be deteriorated at a high temperature and the color of the salt may be changed.
상기 제염 단계는 가마솥에 재료를 넣어 장작불을 이용하여 가열하는 전통적인 방법을 사용하며, 이 과정에서 원적외선이 방출되어 각 재료들의 천연 생리활성물질을 효율적으로 활성화시키는 역할을 한다. 바람직하게는, 상기 진액제조 단계 역시 가마솥에서 이루어질 수 있다.In the decontamination step, a conventional method is used in which a material is placed in a cauldron and heated using a wood fire. In this process, far-infrared rays are emitted to efficiently activate natural physiologically active materials of the respective materials. Preferably, the step of preparing the safflower may also be performed in a cauldron.
천일염은 바닷물을 염전으로 끌어와 바람과 햇빛으로 수분과 함께 유해 성분을 증발시켜 만든 가공되지 않은 소금으로 굵고 반투명한 육각형의 결정이다. 천일염에는 칼슘, 마그네슘, 아연, 칼륨, 철 등의 무기질과 수분을 많이 함유하고 있다. 본 발명에서 사용되는 천일염은 남해안 다도해 청정지역의 깨끗한 바닷물을 이용하여 자연적으로 제조한 천일염을 사용하였다.It is an untreated salt made of thick, translucent hexagonal crystals, which is made by evaporating harmful substances together with moisture by wind and sunlight. Sun-salt contains calcium, magnesium, zinc, potassium, iron and other minerals and water. The sun-salt used in the present invention is a naturally-occurring sun-dried salt using clean seawater in the clean sea area of the South Sea coast.
상기 단계를 거쳐 제염된 소금은 옹기에 담아 42 내지 50℃의 온도에서 20 내지 60일 동안 황토로 된 숙성실에서 숙성시킨다. The salt decontaminated through the above steps is aged in a mortar with a loess for 20 to 60 days at a temperature of 42 to 50 DEG C in a pot.
옹기는 옹기 기벽의 기공이 내면에 형성된 불순물을 밀어내는 작용을 하게 되어 내용물이 부패하지 않고 장기간 저장할 수 있는 뛰어난 저장능력을 가지고 있어, 발효 또는 숙성의 용도로 매우 적합한 용기이다.Onggi is a container suitable for fermentation or aging because the pores of the pottery wall push out the impurities formed on the inner surface and have excellent storage ability that the contents can be stored for a long period without decaying.
본 발명의 숙성 단계에서는 일반 용기 대신 옹기를 사용함으로써 내용물의 부패 및 불순물로 인한 오염을 예방할 수 있으며, 옹기 안에서 간수와 수분이 다시한번 배출된 소금은 숙성기간이 길어질수록 단단해져 보다 고품질의 소금을 생산할 수 있는 효과가 있다.In the aging step of the present invention, it is possible to prevent the corruption of the contents and the contamination due to the impurities by using the pottery instead of the general container, and the salt in which the water and the water are once discharged in the pottery is hardened as the aging period becomes longer, There is an effect that can be.
또한, 소금을 황토로 된 숙성실에서 숙성시키면 원적외선이 발생하여 유해물질을 제거하면서, 소금의 쓴맛과 짠맛은 순화시키고 불순물이 제거된 소금을 얻을 수 있는 장점이 있다.In addition, when the salt is aged in a yellow mortar, it is advantageous in that far-infrared rays are generated, harmful substances are removed, and the bitter and salty taste of the salt is refined and the impurities are removed.
상기 단계에 의해 숙성된 소금은 용도에 따라 입자의 크기별로 분류하는 단계를 거친 후 연근분말 7 내지 15 중량부와 혼합한다.The salt aged by the above step is classified according to the particle size according to the application, and then mixed with 7 to 15 parts by weight of the lotus root powder.
연근은 연꽃의 땅속 줄기로써, 연근에는 탄닌·철분이 많기 때문에 뛰어난 지혈효과가 있으며, 연근에 들어있는 탄닌은 강력한 수렴작용이 있어 염증을 가라앉히는 소염작용, 지혈작용, 수렴작용을 동시에 하며, 단백질의 응고작용을 하여 특히 구내염에 좋다. 또한 연근은 아스파라긴, 아지닌, 티록신 등의 아미노산이 많고, 펙틴과 비타민 B12, 비타민C 등이 풍부해, 말초 혈액순환을 왕성하게 해서 피부의 신진대사를 좋게 하고 내장 전체의 활동을 부드럽게 하기 때문에 피부를 좋게 만들고, 여드름, 기미 등에도 효과적이다.The lotus root is the underground stem of lotus, and the lotus root has excellent hemostatic effect because it has many tannin and iron. The tannin contained in the lotus root has a strong converging action, so it has antiinflammatory, hemostatic, And it is especially good for stomatitis. The lotus root is rich in amino acids such as asparagine, azine, thyroxine, pectin, vitamin B12 and vitamin C, and it stimulates peripheral blood circulation to improve the metabolism of the skin, Make it good, and it is also effective for acne and spots.
상기 혼합과정을 거친 소금은 포장 단위별로 소량 또는 대량의 용기에 포장한다.
The salt that has undergone the above mixing process is packed in a small amount or a large amount of containers per packaging unit.
이하, 본 발명의 실시예에 대하여 설명한다.Hereinafter, embodiments of the present invention will be described.
실시예Example
연잎 및 연대 20kg, 뽕나무 가지 및 뿌리 50kg, 다시마 15kg, 표고버섯 15kg, 감초 3kg을 선별하여 세척하고 불순물을 제거하였다. 상기 선별된 재료들을 물 300L와 함께 가마솥에서 15시간 가열하여 진액을 제조하였다. 진액 제조 후, 천일염 100kg을 가마솥에 넣고 320℃ 온도에서 바닥을 긁어주며 6시간 가열하였다. 이 때 상기 진액을 7회에 걸쳐 첨가하였으며, 한 번에 첨가하는 진액의 양은 15L였다. 이 때 상기 제염 과정을 거친 소금을 옹기에 담아 45℃를 유지하면서 황토로 된 숙성실에서 50일 동안 숙성시켰다. 숙성된 소금을 굵기에 따라 분류하고, 분류된 소금 500g에 연근분말 50g을 혼합하였다. 혼합된 소금은 포장 단위별로 용기에 포장하여 본 발명의 소금을 제조하였다.
20kg of young leaves and young leaves, 50kg of mulberry branches and roots, 15kg of kelp, 15kg of shiitake mushrooms and 3kg of licorice were selectively washed and impurities were removed. The selected materials were heated in a cauldron together with 300 L of water for 15 hours to prepare seaweed. After the preparation of the shampoo, 100 kg of the sun salt was placed in a cauldron and heated at 320 ° C for 6 hours while scraping the floor. At this time, the juice was added seven times, and the amount of juice added at one time was 15L. At this time, the salt having been subjected to the decontamination process was put in a pot and aged for 50 days in a yellow loam while maintaining the temperature at 45 ° C. The aged salt was classified according to the thickness, and 50 g of the lotus root powder was mixed with 500 g of the classified salt. The mixed salt was packed in a container for each package to prepare the salt of the present invention.
이상에서는 본 발명의 바람직한 실시예에 대해서 설명하였으나, 본 발명은 상술한 특정의 실시예에 한정되지 아니하며, 당해 기술분야에서 통상의 지식을 가진 자라면 본원 발명의 요지를 벗어남이 없이 다양한 변형 실시가 가능함은 물론이다. 따라서, 본 발명의 범위는 위의 실시예에 국한해서 해석되어서는 안되며, 후술하는 특허청구범위 뿐만 아니라 이 특허청구범위와 균등한 것들에 의해 정해져야 할 것이다.While the present invention has been described in connection with what is presently considered to be practical exemplary embodiments, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, Of course it is possible. Accordingly, the scope of the present invention should not be construed as being limited to the above-described embodiments, but should be determined by equivalents to the appended claims, as well as the following claims.
Claims (5)
연잎 및 연대 4 내지 8 중량부,
뽕나무 가지 및 뿌리 11 내지 25 중량부,
다시마 3 내지 8 중량부,
표고버섯 3 내지 8 중량부, 및
감초 0.5 내지 2 중량부를 포함하는 재료를 첨가하고 12 내지 20시간 동안 가열하여 진액을 제조하는 단계;
(B) 천일염을 용기에 넣고 270 내지 350℃의 온도에서 4 내지 7시간 동안 상기 용기의 바닥을 긁으며 가열하고, 5 내지 10회에 걸쳐 상기 진액을 상기 천일염에 첨가하여 제염하는 단계; 및
(C) 상기 단계 (B)에서 제염한 소금을 42 내지 50℃에서 20 내지 60일 동안 숙성시키는 단계를 포함하는 소금 제조방법.(A) 100 parts by weight of water,
4 to 8 parts by weight of lotus leaf and date,
11 to 25 parts by weight of mulberry branches and roots,
3 to 8 parts by weight of kelp,
3 to 8 parts by weight of shiitake mushroom, and
0.5 to 2 parts by weight of licorice is added and heated for 12 to 20 hours to prepare a seaweed;
(B) placing the salt in a container, scratching and heating the bottom of the container for 4 to 7 hours at a temperature of 270 to 350 DEG C, and adding the salt to the salt for 5 to 10 times to decontaminate; And
(C) aging the salt decontaminated in step (B) at 42 to 50 DEG C for 20 to 60 days.
상기 단계 (B)의 용기는 가마솥인 것을 특징으로 하는 소금 제조방법.The method according to claim 1,
Wherein the vessel of step (B) is a cauldron.
상기 단계 (C)의 숙성은 황토로 된 숙성실에서 이루어지는 것을 특징으로 하는 소금 제조방법.The method according to claim 1,
Wherein the aging in step (C) is carried out in an aged room made of loess.
상기 단계 (C) 이후에,
상기 숙성된 소금 100 중량부 당 연근분말 7 내지 15 중량부를 혼합하는 단계를 더 포함하는 것을 특징으로 하는 소금 제조방법.The method according to claim 1,
After the step (C)
Further comprising mixing 7 to 15 parts by weight of a lotus root powder per 100 parts by weight of the aged salt.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130103969A KR20150025861A (en) | 2013-08-30 | 2013-08-30 | Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130103969A KR20150025861A (en) | 2013-08-30 | 2013-08-30 | Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150025861A true KR20150025861A (en) | 2015-03-11 |
Family
ID=53022001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR20130103969A KR20150025861A (en) | 2013-08-30 | 2013-08-30 | Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150025861A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102332053B1 (en) * | 2021-05-25 | 2021-12-01 | 원플랫 주식회사 | Method for producing functional salt |
KR20220081619A (en) * | 2020-12-09 | 2022-06-16 | 박진규 | Manufacturing Method of Wild Ginseng Syrup |
CN115736230A (en) * | 2022-11-09 | 2023-03-07 | 四川登顶科技有限责任公司 | Composite edible salt and preparation method thereof |
-
2013
- 2013-08-30 KR KR20130103969A patent/KR20150025861A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220081619A (en) * | 2020-12-09 | 2022-06-16 | 박진규 | Manufacturing Method of Wild Ginseng Syrup |
KR102332053B1 (en) * | 2021-05-25 | 2021-12-01 | 원플랫 주식회사 | Method for producing functional salt |
CN115736230A (en) * | 2022-11-09 | 2023-03-07 | 四川登顶科技有限责任公司 | Composite edible salt and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102835641B (en) | Areca nut brine | |
KR101612813B1 (en) | Manufacturing method of fermented salt containing ginseng steaed red juice | |
KR20210068967A (en) | Composition for relieving and preventing hangover comprising dendropanax morbifera extract | |
CN101380128B (en) | Zhukui multifunctional health care beverage and production method thereof | |
KR20150025861A (en) | Salt Comprising Extract of Lotus and Mulberry and Preparation Method thereof | |
CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
KR101229598B1 (en) | Method for producing salt | |
CN103082272B (en) | Preparation method of acid-pickled needle mushroom with functions of clearing away heat and toxic materials | |
CN104877853A (en) | Pumpkin/cherry nutrient fruit wine and preparation method thereof | |
KR20160067347A (en) | Manufacturing method of spices for a pepper-pot soup | |
CN102018158A (en) | Aloe jam | |
CN103250829B (en) | Lotus plumule tea beverage | |
CN115736052A (en) | Pericarpium citri reticulatae cordyceps militaris Pu' er tea and preparation method thereof | |
KR100837140B1 (en) | Method for preparation of health drink and its health drink | |
CN105580926A (en) | Formula of selenium-containing beverage | |
KR20070005954A (en) | The biofunctional dried fish and pickled fish manufacture method | |
KR20040102921A (en) | A manufacture method of functional salt | |
KR101404204B1 (en) | Method of manufacturing mulberry salt | |
CN107509978A (en) | A kind of instant heavy wool gumbo salted egg and preparation method thereof | |
KR101341162B1 (en) | method manufacture and annex drink use bark pine extract | |
KR102662891B1 (en) | Salt processing method using sea cucumber hot water extract | |
KR101195322B1 (en) | Garlic powder compositions and the method of making it | |
CN104642576A (en) | Preparation method of concentrated health-care health-preserving tea product | |
KR20050080501A (en) | A making method of health assistance food for high blood pressure, fatness, diabetes patients. | |
KR101800787B1 (en) | The manufacturing method of ginseng dried radish leaf rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |